Fibroblast Rejuvenation via Mechanical Reprogramming

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for rejuvenating fibroblast cells, such as stem cell and induced pluripotent stem cell transplantation, often introduce genomic mutations that increase oncogenic potential, necessitating a non-genetic approach for fibroblast rejuvenation that maintains high DNA fidelity and enhanced cytoskeletal gene expression.

Innovation Solution

A method involving mechanical reprogramming of fibroblasts through laterally confined growth on micro-patterned substrates followed by redifferentiation in a 3D collagen matrix of varying densities, which induces stem-cell like characteristics and enhances acto-myosin contractility and matrix remodeling without genetic or biochemical interventions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If stem cell or induced pluripotent stem cell transplantation is used to rejuvenate fibroblasts, then fibroblast function is restored, but genomic mutations are introduced that increase oncogenic potential

Engineering Contradiction:

Improvefibroblast function restorationVSAvoidgenomic mutations and oncogenic potential

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces genetic/biochemical reprogramming methods with mechanical reprogramming through micro-patterned substrates and controlled physical confinement. Fibroblasts are cultured on micropatterned surfaces with specific geometric constraints that mechanically induce stem cell-like characteristics and rejuvenation without introducing genomic mutations, thus resolving the contradiction between functional restoration and oncogenic risk

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes physical parameters (substrate stiffness, micropattern geometry, cell confinement dimensions) to induce fibroblast rejuvenation. By adjusting these mechanical parameters rather than genetic parameters, the method achieves functional restoration while avoiding the harmful genomic mutations associated with traditional stem cell approaches

Inventive Principle:

Principle #35Parameter changes

2Reliability

If mechanical reprogramming is used to rejuvenate fibroblasts, then DNA fidelity is maintained, but the complexity of the mechanical reprogramming process increases

Engineering Contradiction:

ImproveDNA fidelityVSAvoidmechanical reprogramming process complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The mechanical reprogramming process is segmented into distinct stages: initial micropatterned substrate attachment, lateral confinement growth phase, and 3D matrix embedding phase. Each stage has specific geometric parameters that guide the progressive rejuvenation process, making the complex mechanism manageable and reproducible while maintaining DNA fidelity

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent transitions cells from 2D micropatterned substrate growth to 3D matrix embedding, using dimensional transition as a control mechanism for reprogramming progression. This dimensional change provides a structured approach to managing process complexity while ensuring reliable rejuvenation outcomes

Inventive Principle:

Principle #17Another dimension (Dimensionality change)

3Reliability

If fibroblasts are grown under lateral confinement to induce stem cell characteristics, then cytoskeletal gene expression is enhanced, but the growth conditions become more restrictive

Engineering Contradiction:

Improvecytoskeletal gene expressionVSAvoidgrowth condition restrictiveness

Core Design Contradiction:

ReliabilityVSEase of operation

Solution Approach 1:

The patent applies local geometric constraints through micropatterned substrates where only specific regions provide lateral confinement. This localized restriction enhances cytoskeletal gene expression in confined areas while leaving other regions accessible, balancing the need for enhanced expression with operational ease

Inventive Principle:

Principle #3Local quality

Data Source

PatentUS20230235289A1Method for fibroblast rejuvenation by mechanical reprogramming and redifferentiation

Publication Date: 2023.07.27 PAUL SCHERRER INSTITUT

AI summary

Over the course of an aging process fibroblasts lose contractility, leading to reduced connective tissue stiffness. A promising therapeutic avenue for functional rejuvenation of connective tissue is reprogrammed fibroblast replacements with a laterally confined growth of fibroblasts on micro-patterned substrates that induces stem cell-like spheroids. The partially reprogrammed spheroids are embedded in collagen-I matrices of varying densities, mimicking different 3D tissue constraints. The spheroids regain their fibroblastic properties and sprout to form 3D connective tissue networks. The differentiated fibroblasts exhibit reduced DNA damage, enhanced cytoskeletal gene expression and acto-myosin contractility. The rejuvenated fibroblasts show increased matrix protein (fibronectin and laminin) deposition and collagen remodeling compared to the parental fibroblast tissue network. The partially reprogrammed cells have comparatively open chromatin compaction states and may be more poised to redifferentiation into contractile fibroblasts in 3D-collagen matrix. Collectively, the results highlight efficient fibroblast rejuvenation, with important implications in regenerative medicine.